Синтез омепразола для ингибиторов протонной помпы

Контроль кислотности желудка с помощью хирально-селективной химии

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Обзор

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Химический процесс

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Сырьё

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Конечные продукты

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Соображения безопасности

Последние инновации

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Масштаб производства

800

тонн/год

$3.5 billion

Рыночная стоимость

Больше в Pharmaceutical & Drug Manufacturing

Полусинтетическое производство амоксициллина

Global Industrial Scale

Производство пенициллина G методом ферментации

Global Industrial Scale

Производство рекомбинантного человеческого инсулина

Global Industrial Scale

Синтез аспирина ацетилированием салициловой кислоты

Global Industrial Scale

Синтез ибупрофена — зелёный процесс BHC

Global Industrial Scale

Синтез метформина гидрохлорида

Global Industrial Scale

Синтез парацетамола (ацетаминофена)

Global Industrial Scale

Frequently Asked Questions

What industry uses Синтез омепразола для ингибиторов протонной помпы?
Синтез омепразола для ингибиторов протонной помпы is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Синтез омепразола для ингибиторов протонной помпы?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Синтез омепразола для ингибиторов протонной помпы?
Синтез омепразола для ингибиторов протонной помпы has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Синтез омепразола для ингибиторов протонной помпы?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Синтез омепразола для ингибиторов протонной помпы?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).